Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Exosome Research Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.
The exosome research market has grown exponentially in recent years. It will grow from $210.62 billion in 2023 to $283.43 billion in 2024 at a compound annual growth rate (CAGR) of 34.6%. The exosome research market is expected to see exponential growth in the next few years. It will grow to $865.26 billion in 2028 at a compound annual growth rate (CAGR) of 32.2%.
The expansion observed in the historical period can be ascribed to an enhanced comprehension of exosome biology, augmented investment in life sciences research, the advent of liquid biopsies, a heightened emphasis on personalized medicine, and collaborative research initiatives.
The profound growth projected in the exosome research market is underpinned by the escalating incidence of chronic diseases worldwide. Advanced research in exosomes plays a crucial role in the understanding and therapeutic approach toward an array of illnesses such as cancer, neurodegenerative, and inflammatory diseases.
Technological Pioneering by Major Market Players
Deepening investments in technological innovations by major industry players are further invigorating market growth. These companies are at the forefront of developing sophisticated platforms for the characterization and analysis of exosomes, which contributes to monumental strides in medicine, diagnostics, and drug delivery. The report highlights the burgeoning collaborations aimed at enhancing exosome-related methodologies that promise to reshape future healthcare landscapes.
With particular attention to North America, the report discusses how this region stands as the trailblazer in the exosome research sphere, buoyed by robust investment in life sciences and cutting-edge technological advancements. The market's progression in North America is emblematic of the global surge in demand for exosome research applications and solutions.
- Strategic acquisitions and partnerships within the industry fostering a center of excellence focused on next-gen exosome manufacturing technologies.
- Significant trends encompassing clinical applications, therapeutic advancements, and biomarker identification bolstering market enlargement.
- The advent of inventive products by key market players aiming to augment research effectiveness and capitalize on emerging market opportunities.
Comprehensive Market Insights for Informed Decision-Making
The research provides detailed market segmentation analysis, including kits and reagents, instruments, and related tools, with a breakdown of applications across diverse indications such as cancer research and cardiovascular diseases. The report offers a valuable resource for stakeholders in academic and research institutes, pharmaceutical and biotechnology companies, and healthcare facilities seeking to stay abreast of market trends and opportunities.
A selection of companies mentioned in this report includes
- Thermo Fisher Scientific Inc.
- System Biosciences LLC
- QIAGEN N.V.
- Exosome Diagnostics Inc.
- Bio-Techne Corporation
- Hitachi Ltd.
- Aethlon Medical Inc.
- NanoSomiX Inc.
- Malvern Panalytical Ltd.
- Sistemic Scotland Limited
- NX PharmaGen Corporation
- Miltenyi Biotec GmbH
- AMS Biotechnology (Europe) B.V.
- Norgen Biotek Corp.
- Novus Biologicals LLC
- Lonza Group AG
- Sistem-Bio S.A.S.
- Izon Science Ltd
- Evomic Science LLC
- New England Biolabs Inc.
- Evox Therapeutics Limited
- Codiak BioSciences Inc.
- MagBio Genomics Inc.
- Cell Guidance Systems Ltd.
- Aruna Biomedical PBC
- CureMetrix Inc.
- Capricor Therapeutics Inc.
- Stemcell Technologies Inc.
- ExoCoBio Inc.
- Creative Biolabs
- ArcherDX Inc.
- Nanovex Biotechnologies S.L.
For more information about this report visit https://www.researchandmarkets.com/r/9y1slr
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
